BullFrog AI Holdings, Inc. (BFRGW)

NASDAQ · Pharmaceuticals & Biotech · Pharmaceutical Preparations

Price
$0.11
Day
+19.80%

Close 2026-09-22.

The company

Overview Most new therapeutics will fail at some point in preclinical or clinical development. This is the primary driver of the high cost of developing new therapeutics. A major challenge in developing new therapeutics is efficiently integrating the complex, high-dimensional data generated at each stage of development to help de-risk subsequent stages of the process. Artificial intelligence and machine learning (“AI/ML”) has emerged as a digital solution to help address this problem. use AI/ML to advance medicines for both internal and external projects. We are committed to increasing the probability of success and decreasing the time and cost involved in developing therapeutics. Most current AI/ML platforms still fall short in their ability to synthesize disparate, high-dimensional data for actionable insight. Our platform technology, bfLEAP™, is an analytical AI/ML platform derived from technology developed at The Johns Hopkins University Applied Physics Laboratory (“JHU-APL”), which is able to surmount the challenges of scalability and flexibility currently hindering researchers and clinicians by providing a more precise 1 , multi-dimensional understanding of their data.

From Item 1: Overview · Most.

Institutional holders

Largest positions reported on Form 13F for the quarter ended 2026-06-30, by value.

Recent filings